| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/30/2012 | CN102477071A Pro-Ala-Lys-Lys(Pro-Ala-Lys)-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent |
| 05/30/2012 | CN101735309B Iridovirus antigen active polypeptide and application thereof |
| 05/30/2012 | CN101735307B Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof |
| 05/30/2012 | CN101597323B Radioactive isotope labeling polypeptide for tumor imaging |
| 05/30/2012 | CN101570568B ACE inhibitory peptide in fermented milk and preparation method thereof |
| 05/30/2012 | CN101456901B 12 peptide ZA for inhibiting hepatitis c virus to infect human cell and preparation method and application |
| 05/30/2012 | CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides |
| 05/30/2012 | CN101068829B 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| 05/29/2012 | US8188217 Methods for the synthesis of dicarba bridges in organic compounds |
| 05/29/2012 | US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 05/29/2012 | US8188053 Anti-inflammatory peptides |
| 05/29/2012 | US8188049 Peptides having activities of epidermal growth factor and its uses |
| 05/29/2012 | US8188033 Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity |
| 05/29/2012 | US8187605 Means for the inhibition of anti-β1-adrenergic receptor antibodies |
| 05/29/2012 | CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/29/2012 | CA2338005C Peptide antagonists of zonulin and methods for use of the same |
| 05/24/2012 | WO2012066293A1 Therapeutic agent |
| 05/24/2012 | WO2012006497A3 Mu opioid receptor agonist analogs of the endomorphins |
| 05/24/2012 | US20120130146 Continuous administration of cilengitide in cancer treatments |
| 05/24/2012 | US20120130017 Process and new compounds |
| 05/24/2012 | US20120129776 Bioactive peptides and method of using same |
| 05/24/2012 | US20120129771 Peptides and related molecules that modulate nerve growth factor activity |
| 05/24/2012 | US20120129764 Influenza a and b virus replication-inhibiting peptides |
| 05/24/2012 | US20120129758 Muscle function enhancing peptide |
| 05/24/2012 | US20120129264 Method for Transforming a Bacterium Belonging to the Streptococcus Genus by Natural Competence |
| 05/24/2012 | US20120128756 Skin Permeating And Cell Entering (SPACE) Peptides and Methods of Use Thereof |
| 05/24/2012 | US20120128708 Diagnostic mycobacterium tuberculosis test |
| 05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
| 05/24/2012 | US20120128704 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
| 05/24/2012 | US20120128680 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
| 05/24/2012 | US20120128646 Methods and compositions for the treatment of autoimmune disease |
| 05/23/2012 | EP2455388A1 Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| 05/23/2012 | EP2455105A2 Bombesin analogues |
| 05/23/2012 | EP2455098A1 New cyclic peptide compounds |
| 05/23/2012 | EP2454276A1 Therapeutic agents |
| 05/23/2012 | EP2454272A1 Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
| 05/23/2012 | EP2454271A2 Peptides whose uptake in cells is controllable |
| 05/23/2012 | EP2453926A2 Peptides whose uptake in cells is controllable |
| 05/23/2012 | EP1848731B1 Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof |
| 05/23/2012 | EP1781780B1 Treating cancer |
| 05/23/2012 | EP1678210B1 Anti-nik antibodies and uses thereof |
| 05/23/2012 | EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 05/23/2012 | CN102471370A 用于影响培养中的梭菌分化的方法和组合物 For influencing the differentiation of cultures of Clostridium methods and compositions |
| 05/23/2012 | CN102471368A Chromatographic processes and purified compounds thereof |
| 05/23/2012 | CN102464704A Novel compound, its preparation method and application |
| 05/23/2012 | CN102464703A Method for obtaining high purity echinocandin D |
| 05/23/2012 | CN102464702A 制备醋酸亮丙瑞林的方法、产品及用途 Leuprolide preparation methods, products and uses |
| 05/23/2012 | CN102229658B Anti-rheumatoid arthritis polypeptide and its application in pharmacy |
| 05/23/2012 | CN102229657B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN102229656B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN102229655B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229654B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229653B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229652B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN101906143B Conjugate of two Arg-Gly-Asp chains and one fatty alcohol chain through Lys, synthesis and medicine application thereof |
| 05/23/2012 | CN101870724B PLAC1 (Placenta-specific 1) anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
| 05/23/2012 | CN101665531B Lepista sordida protein LsAPII as well as preparation method and application thereof |
| 05/23/2012 | CN101580540B Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof |
| 05/23/2012 | CN101531705B Method for purifying Carbetocin |
| 05/23/2012 | CN101519426B Lactalbumin polypeptide with antioxidation activity and preparation method thereof |
| 05/23/2012 | CN101508724B Method of preparing tetradecapeptide somatostatin |
| 05/23/2012 | CN101407539B Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use |
| 05/22/2012 | US8183212 Compound having GPR54 agonistic activity |
| 05/22/2012 | US8183211 Pharmaceutical compositions for inhibiting intestinal permeability |
| 05/22/2012 | US8183202 Use of type-B lantibiotic-based compounds having antimicrobial activity |
| 05/22/2012 | US8183055 Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same |
| 05/22/2012 | US8182996 Compositions and methods for detecting Klebsiella pneumoniae |
| 05/22/2012 | CA2660208C Cyclic angiotensin analogs |
| 05/22/2012 | CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/22/2012 | CA2348956C Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/18/2012 | WO2012065034A1 Enolase peptide conjugate vaccines against staphylococcus aureus |
| 05/18/2012 | WO2012064429A2 Skin permeating and cell entering (space) peptides and methods of use thereof |
| 05/18/2012 | WO2012062977A1 Dermatopontin-activating peptides and cosmetic compositions including same |
| 05/18/2012 | WO2012062953A1 P38 inhibitor peptide and uses thereof |
| 05/18/2012 | WO2012062906A1 Peptides as bioactive compounds |
| 05/18/2012 | WO2012062214A1 Caspofungin analog, and preparation method and applications thereof |
| 05/18/2012 | WO2012062213A1 Caspofungin analog and applications thereof |
| 05/18/2012 | WO2012062212A1 Preparation method for caspofungin analog |
| 05/18/2012 | WO2012061937A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
| 05/18/2012 | WO2012015979A3 Hmgb1-derived peptides enhance immune response to antigens |
| 05/18/2012 | CA2817373A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
| 05/18/2012 | CA2811113A1 Skin permeating and cell entering (space) peptides and methods of use thereof |
| 05/17/2012 | US20120123090 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof |
| 05/17/2012 | US20120122803 Alpha-conotoxin mii analogs |
| 05/17/2012 | US20120122799 Cyclic peptide antitumor agents |
| 05/17/2012 | US20120122797 Peptidic compound and use of same |
| 05/17/2012 | US20120122788 E-polylysine conjugates and the use thereof |
| 05/17/2012 | US20120122786 Use of Polypeptide Micromolecule MLIF in Preparing Medicine for Preventing and Treating Myocardial Ischemia |
| 05/17/2012 | US20120122781 Peptide ligands of somatostatin receptors |
| 05/17/2012 | US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN |
| 05/17/2012 | US20120122766 Novel Polypeptide Having Angiogenesis-Inducing Activity And Antibacterial Activity, And Use Thereof For Medical Purposes |
| 05/17/2012 | US20120122177 Viral Infection Enhancing Peptide |
| 05/17/2012 | US20120122157 Signal Peptide for Producing a Polypeptide |
| 05/17/2012 | US20120122153 Acid-clevable linkers exhibiting altered rates of acid hydrolysis |
| 05/17/2012 | US20120121706 PAR-1 Activation by Metalloproteinase-1 (MMP-1) |
| 05/17/2012 | US20120121682 cRGD PEPTIDE DERIVATIVE AND ITS MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING A cRGD PEPTIDE DERIVATIVE |
| 05/17/2012 | US20120121675 Compounds which inhibit muscle contraction |
| 05/17/2012 | US20120121633 Hiv cd4 binding site based covalent immunogen compositions |
| 05/17/2012 | US20120121627 Peptides for active anti-cytokine immunization |
| 05/17/2012 | US20120121625 Peptide |